Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


Articles published in Virology

Retrieve available abstracts of 85 articles:
HTML format
Text format



Single Articles


    October 2018
  1. GONZALEZ-PARRA G, Dobrovolny HM
    A quantitative assessment of dynamical differences of RSV infections in vitro and in vivo.
    Virology. 2018;523:129-139.
    PubMed     Text format     Abstract available


  2. MORGENE MF, Maurin C, Pillet S, Berthelot P, et al
    HaCaT epithelial cells as an innovative novel model of rhinovirus infection and impact of clarithromycin treatment on infection kinetics.
    Virology. 2018;523:27-34.
    PubMed     Text format     Abstract available


    September 2018
  3. CUI L, Mahesutihan M, Zheng W, Meng L, et al
    CDC25B promotes influenza A virus replication by regulating the phosphorylation of nucleoprotein.
    Virology. 2018;525:40-47.
    PubMed     Text format     Abstract available


  4. LI L, DeLiberto TJ, Killian ML, Torchetti MK, et al
    Evolutionary pathway for the 2017 emergence of a novel highly pathogenic avian influenza A(H7N9) virus among domestic poultry in Tennessee, United States.
    Virology. 2018;525:32-39.
    PubMed     Text format     Abstract available


  5. XIAO Y, Nolting JM, Sheng ZM, Bristol T, et al
    Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds.
    Virology. 2018;524:182-191.
    PubMed     Text format     Abstract available


  6. KIM KH, Kwon YM, Lee YT, Hwang HS, et al
    Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
    Virology. 2018;524:172-181.
    PubMed     Text format     Abstract available


    August 2018
  7. OHTA K, Matsumoto Y, Yumine N, Nishio M, et al
    The V protein of human parainfluenza virus type 2 promotes RhoA-induced filamentous actin formation.
    Virology. 2018;524:90-96.
    PubMed     Text format     Abstract available


  8. ZARUBAEV VV, Pushkina EA, Borisevich SS, Galochkina AV, et al
    Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
    Virology. 2018;524:69-77.
    PubMed     Text format     Abstract available


  9. SHIBATA A, Okamatsu M, Sumiyoshi R, Matsuno K, et al
    Repeated detection of H7N9 avian influenza viruses in raw poultry meat illegally brought to Japan by international flight passengers.
    Virology. 2018;524:10-17.
    PubMed     Text format     Abstract available


    July 2018
  10. SUTTIE A, Karlsson EA, Deng YM, Horm SV, et al
    Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.
    Virology. 2018;523:22-26.
    PubMed     Text format     Abstract available


  11. WANG Z, Huang B, Thomas M, Sreenivasan CC, et al
    Detailed mapping of the linear B Cell epitopes of the hemagglutinin (HA) protein of swine influenza virus.
    Virology. 2018;522:131-137.
    PubMed     Text format     Abstract available


  12. CORREIA V, Abecasis AB, Rebelo-de-Andrade H
    Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.
    Virology. 2018;522:122-130.
    PubMed     Text format     Abstract available


  13. SHCHERBIK S, Carney P, Pearce N, Stevens J, et al
    Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
    Virology. 2018;522:65-72.
    PubMed     Text format     Abstract available


  14. GAMBARYAN AS, Matrosovich TY, Boravleva EY, Lomakina NF, et al
    Receptor-binding properties of influenza viruses isolated from gulls.
    Virology. 2018;522:37-45.
    PubMed     Text format     Abstract available


    May 2018
  15. LI Y, Sun L, Zheng W, Madina Mahesutihan, et al
    Phosphorylation and dephosphorylation of threonine 188 in nucleoprotein is crucial for the replication of influenza A virus.
    Virology. 2018;520:30-38.
    PubMed     Text format     Abstract available


    April 2018
  16. LI J, Zhang K, Chen Q, Zhang X, et al
    Three amino acid substitutions in the NS1 protein change the virus replication of H5N1 influenza virus in human cells.
    Virology. 2018;519:64-73.
    PubMed     Text format     Abstract available


    March 2018
  17. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Kotomina T, et al
    Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.
    Virology. 2018;518:313-323.
    PubMed     Text format     Abstract available


  18. CHRZASTEK K, Lee DH, Gharaibeh S, Zsak A, et al
    Characterization of H9N2 avian influenza viruses from the Middle East demonstrates heterogeneity at amino acid position 226 in the hemagglutinin and potential for transmission to mammals.
    Virology. 2018;518:195-201.
    PubMed     Text format     Abstract available


    February 2018
  19. ZHANG S, Cheng Q, Luo C, Yin L, et al
    An alanine residue in human parainfluenza virus type 3 phosphoprotein is critical for restricting excessive N(0)-P interaction and maintaining N solubility.
    Virology. 2018;518:64-76.
    PubMed     Text format     Abstract available


  20. RAMEY AM, DeLiberto TJ, Berhane Y, Swayne DE, et al
    Lessons learned from research and surveillance directed at highly pathogenic influenza A viruses in wild birds inhabiting North America.
    Virology. 2018;518:55-63.
    PubMed     Text format     Abstract available


  21. RAJAO DS, Anderson TK, Kitikoon P, Stratton J, et al
    Antigenic and genetic evolution of contemporary swine H1 influenza viruses in the United States.
    Virology. 2018;518:45-54.
    PubMed     Text format     Abstract available


    January 2018
  22. RODRIGUEZ L, Reedy S, Nogales A, Murcia PR, et al
    Development of a novel equine influenza virus live-attenuated vaccine.
    Virology. 2018;516:76-85.
    PubMed     Text format     Abstract available


  23. OISHI K, Yamayoshi S, Kawaoka Y
    Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast.
    Virology. 2018;516:71-75.
    PubMed     Text format     Abstract available


  24. LEE YN, Lee EK, Song BM, Heo GB, et al
    Evaluation of the zoonotic potential of multiple subgroups of clade 2.3.4.4 influenza A (H5N8) virus.
    Virology. 2018;516:38-45.
    PubMed     Text format     Abstract available


    December 2017
  25. SUN H, Yao W, Wang K, Qian Y, et al
    Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses.
    Virology. 2017;514:230-239.
    PubMed     Text format     Abstract available


  26. HERRERA-RODRIGUEZ J, Meijerhof T, Niesters HG, Stjernholm G, et al
    A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.
    Virology. 2017;515:21-28.
    PubMed     Text format     Abstract available


    November 2017
  27. AUMAYR M, Schrempf A, Uzulmez O, Olek KM, et al
    Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection.
    Virology. 2017;511:123-134.
    PubMed     Text format     Abstract available


    October 2017
  28. NI F, Kondrashkina E, Wang Q
    Determinant of receptor-preference switch in influenza hemagglutinin.
    Virology. 2017;513:98-107.
    PubMed     Text format     Abstract available


  29. LION A, Richard M, Esnault E, Kut E, et al
    Productive replication of avian influenza viruses in chicken endothelial cells is determined by hemagglutinin cleavability and is related to innate immune escape.
    Virology. 2017;513:29-42.
    PubMed     Text format     Abstract available


  30. LAU JW, Kim YI, Murphy R, Newman R, et al
    Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.
    Virology. 2017;510:289-296.
    PubMed     Text format     Abstract available


  31. YE Z, Ren L, Tang Z, Deng Y, et al
    Pulmonary C-fiber degeneration downregulates IFN-gamma receptor 1 via IFN-alpha induction to attenuate RSV-induced airway hyperresponsiveness.
    Virology. 2017;510:262-272.
    PubMed     Text format     Abstract available


    September 2017
  32. TAKEMAE N, Tsunekuni R, Sharshov K, Tanikawa T, et al
    Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016-2017.
    Virology. 2017;512:8-20.
    PubMed     Text format     Abstract available


  33. WILSON JR, Belser JA, DaSilva J, Guo Z, et al
    An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.
    Virology. 2017;511:214-221.
    PubMed     Text format     Abstract available


    August 2017
  34. CHEN W, Xu Q, Zhong Y, Yu H, et al
    Genetic variation and co-evolutionary relationship of RNA polymerase complex segments in influenza A viruses.
    Virology. 2017;511:193-206.
    PubMed     Text format     Abstract available


  35. NAGUIB MM, Arafa AS, Parvin R, Beer M, et al
    Insights into genetic diversity and biological propensities of potentially zoonotic avian influenza H9N2 viruses circulating in Egypt.
    Virology. 2017;511:165-174.
    PubMed     Text format     Abstract available


  36. BELSER JA, Johnson A, Pulit-Penaloza JA, Pappas C, et al
    Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.
    Virology. 2017;511:135-141.
    PubMed     Text format     Abstract available


  37. HWANG HS, Lee YT, Kim KH, Ko EJ, et al
    Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
    Virology. 2017;511:142-151.
    PubMed     Text format     Abstract available


  38. ABENTE EJ, Gauger PC, Walia RR, Rajao DS, et al
    Detection and characterization of an H4N6 avian-lineage influenza A virus in pigs in the Midwestern United States.
    Virology. 2017;511:56-65.
    PubMed     Text format     Abstract available


  39. ROJO GL, Goya S, Orellana M, Sancilio A, et al
    Unravelling respiratory syncytial virus outbreaks in Buenos Aires, Argentina: Molecular basis of the spatio-temporal transmission.
    Virology. 2017;508:118-126.
    PubMed     Text format     Abstract available


    July 2017
  40. NGUYEN LT, Nishi T, Shichinohe S, Chu DH, et al
    Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens.
    Virology. 2017;510:252-261.
    PubMed     Text format     Abstract available


  41. BAJIMAYA S, Frankl T, Hayashi T, Takimoto T, et al
    Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses.
    Virology. 2017;510:234-241.
    PubMed     Text format     Abstract available


  42. ALKHERAIF AA, Topliff CL, Reddy J, Massilamany C, et al
    Type 2 BVDV Npro suppresses IFN-1 pathway signaling in bovine cells and augments BRSV replication.
    Virology. 2017;507:123-134.
    PubMed     Text format     Abstract available


    June 2017
  43. SIKORA D, Rocheleau L, Brown EG, Pelchat M, et al
    Influenza A virus cap-snatches host RNAs based on their abundance early after infection.
    Virology. 2017;509:167-177.
    PubMed     Text format     Abstract available


  44. CHLANDA P
    Influenza Hemagglutinin and M2 ion channel priming by trypsin: Killing two birds with one stone.
    Virology. 2017;509:131-132.
    PubMed     Text format     Abstract available


  45. PATEL H, Kukol A
    Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors.
    Virology. 2017;509:112-120.
    PubMed     Text format     Abstract available


  46. SMITH GE, Sun X, Bai Y, Liu YV, et al
    Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
    Virology. 2017;509:90-97.
    PubMed     Text format     Abstract available


  47. DENG L, Kim JR, Chang TZ, Zhang H, et al
    Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
    Virology. 2017;509:82-89.
    PubMed     Text format     Abstract available


    May 2017
  48. WANG BX, Brown EG, Fish EN
    Residues F103 and M106 within the influenza A virus NS1 CPSF4-binding region regulate interferon-stimulated gene translation initiation.
    Virology. 2017;508:170-179.
    PubMed     Text format     Abstract available


  49. SUN X, Belser JA, Pulit-Penaloza JA, Creager HM, et al
    Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Virology. 2017;508:164-169.
    PubMed     Text format     Abstract available


  50. LIN CY, Chia MY, Chen PL, Yeh CT, et al
    Assessment of pathogenicity and antigenicity of American lineage influenza H5N2 viruses in Taiwan.
    Virology. 2017;508:159-163.
    PubMed     Text format     Abstract available


  51. XU G, Zhang X, Liu Q, Bing G, et al
    PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine.
    Virology. 2017;508:45-53.
    PubMed     Text format     Abstract available


    April 2017
  52. LEE DH, Torchetti MK, Killian ML, Swayne DE, et al
    Deep sequencing of H7N8 avian influenza viruses from surveillance zone supports H7N8 high pathogenicity avian influenza was limited to a single outbreak farm in Indiana during 2016.
    Virology. 2017;507:216-219.
    PubMed     Text format     Abstract available


  53. CHUTIWITOONCHAI N, Mano T, Kakisaka M, Sato H, et al
    Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.
    Virology. 2017;507:32-39.
    PubMed     Text format     Abstract available


  54. HILLYER P, Mane VP, Chen A, Dos Santos MB, et al
    Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.
    Virology. 2017;504:63-72.
    PubMed     Text format     Abstract available


    March 2017
  55. NARKPUK J, Teeravechyan S, Puthavathana P, Jongkaewwattana A, et al
    Single nucleoprotein residue determines influenza A virus sensitivity to an intertypic suppression mechanism.
    Virology. 2017;506:99-109.
    PubMed     Text format     Abstract available


  56. FOUGEROLLE S, Legrand L, Lecouturier F, Sailleau C, et al
    Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors.
    Virology. 2017;505:210-217.
    PubMed     Text format     Abstract available


    February 2017
  57. CHEN LJ, Lin XD, Tian JH, Liao Y, et al
    Diversity, evolution and population dynamics of avian influenza viruses circulating in the live poultry markets in China.
    Virology. 2017;505:33-41.
    PubMed     Text format     Abstract available


  58. CHAIMAYO C, Hayashi T, Underwood A, Hodges E, et al
    Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein.
    Virology. 2017;505:23-32.
    PubMed     Text format     Abstract available


  59. RODRIGUEZ L, Nogales A, Reilly EC, Topham DJ, et al
    A live-attenuated influenza vaccine for H3N2 canine influenza virus.
    Virology. 2017;504:96-106.
    PubMed     Text format     Abstract available


    January 2017
  60. LEE YH, Jang YH, Seong BL
    Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Virology. 2017;504:73-78.
    PubMed     Text format     Abstract available


  61. PEETERS B, Reemers S, Dortmans J, de Vries E, et al
    Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Virology. 2017;503:83-93.
    PubMed     Text format     Abstract available


  62. RABBANI MA, Barik S
    5-Hydroxytryptophan, a major product of tryptophan degradation, is essential for optimal replication of human parainfluenza virus.
    Virology. 2017;503:46-51.
    PubMed     Text format     Abstract available


  63. KIM SH, Paldurai A, Samal SK
    A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
    Virology. 2017;503:31-36.
    PubMed     Text format     Abstract available


    December 2016
  64. PEARCE MB, Pappas C, Gustin KM, Davis CT, et al
    Enhanced virulence of clade 2.3.2.1 highly pathogenic avian influenza A H5N1 viruses in ferrets.
    Virology. 2016;502:114-122.
    PubMed     Text format     Abstract available


  65. SUPTAWIWAT O, Ninpan K, Boonarkart C, Ruangrung K, et al
    Evolutionary dynamic of antigenic residues on influenza B hemagglutinin.
    Virology. 2016;502:84-96.
    PubMed     Text format     Abstract available


  66. BELSER JA, Sun X, Creager HM, Johnson A, et al
    Role of H7 hemagglutinin in murine infectivity of influenza viruses following ocular inoculation.
    Virology. 2016;502:13-19.
    PubMed     Text format     Abstract available


  67. PUSHKO P, Tretyakova I, Hidajat R, Zsak A, et al
    Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
    Virology. 2016;501:176-182.
    PubMed     Text format     Abstract available


  68. BAJIMAYA S, Hayashi T, Frankl T, Bryk P, et al
    Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses.
    Virology. 2016;501:127-135.
    PubMed     Text format     Abstract available


    November 2016
  69. HU M, Yuan S, Zhang K, Singh K, et al
    PB2 substitutions V598T/I increase the virulence of H7N9 influenza A virus in mammals.
    Virology. 2016;501:92-101.
    PubMed     Text format     Abstract available


  70. LUO J, Ferguson L, Smith DR, Woolums AR, et al
    Serological evidence for high prevalence of Influenza D Viruses in Cattle, Nebraska, United States, 2003-2004.
    Virology. 2016;501:88-91.
    PubMed     Text format     Abstract available


  71. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Tretiak T, et al
    Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Virology. 2016;500:209-217.
    PubMed     Text format     Abstract available


  72. KOSIK I, Yewdell JW
    Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.
    Virology. 2016;500:178-183.
    PubMed     Text format     Abstract available


  73. GONZALEZ Y, Juarez E, Carranza C, Sada E, et al
    Diminished effector and memory CD8+ circulating T lymphocytes in patients with severe influenza caused by the AH1N1 pdm09 virus.
    Virology. 2016;500:139-148.
    PubMed     Text format     Abstract available


  74. HARTWIG SM, Ketterer M, Apicella MA, Varga SM, et al
    Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.
    Virology. 2016;498:128-35.
    PubMed     Text format     Abstract available


    October 2016
  75. GUJJAR N, Chothe SK, Gawai S, Nissly R, et al
    Co-expression of sialic acid receptors compatible with avian and human influenza virus binding in emus (Dromaius novaehollandiae).
    Virology. 2016;500:114-121.
    PubMed     Text format     Abstract available


  76. CREAGER HM, Zeng H, Pulit-Penaloza JA, Maines TR, et al
    In vitro exposure system for study of aerosolized influenza virus.
    Virology. 2016;500:62-70.
    PubMed     Text format     Abstract available


  77. NOGALES A, Huang K, Chauche C, DeDiego ML, et al
    Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
    Virology. 2016;500:1-10.
    PubMed     Text format     Abstract available


  78. ELBAHESH H, Bergmann S, Russell CJ
    Focal adhesion kinase (FAK) regulates polymerase activity of multiple influenza A virus subtypes.
    Virology. 2016;499:369-374.
    PubMed     Text format     Abstract available


  79. GARG R, Theaker M, Martinez EC, van Drunen Littel-van den Hurk S, et al
    A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus.
    Virology. 2016;499:288-297.
    PubMed     Text format     Abstract available


  80. SHRIVASTAVA P, Sarkar I, Atanley E, Gomis S, et al
    IL-12p40 gene-deficient BALB/c mice exhibit lower weight loss, reduced lung pathology and decreased sensitization to allergen in response to infection with pneumonia virus of mice.
    Virology. 2016;497:1-10.
    PubMed     Text format     Abstract available


    September 2016
  81. CUI P, Deng G, Shi J, Kong H, et al
    New influenza A(H7N7) viruses detected in live poultry markets in China.
    Virology. 2016;499:165-169.
    PubMed     Text format     Abstract available


  82. DEJESUS E, Costa-Hurtado M, Smith D, Lee DH, et al
    Changes in adaptation of H5N2 highly pathogenic avian influenza H5 clade 2.3.4.4 viruses in chickens and mallards.
    Virology. 2016;499:52-64.
    PubMed     Text format     Abstract available


  83. ISHIKAWA H, Fukui T, Ino S, Sasaki H, et al
    Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung.
    Virology. 2016;499:23-29.
    PubMed     Text format     Abstract available


  84. RAUFF D, Strydom C, Abolnik C
    Evolutionary consequences of a decade of vaccination against subtype H6N2 influenza.
    Virology. 2016;498:226-239.
    PubMed     Text format     Abstract available


    April 2016
  85. HWANG HS, Lee YT, Kim KH, Park S, et al
    Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Virology. 2016;494:215-224.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: